Trial Profile
Study to Evaluate OMR-12200 as a Negative Contrast Agent for Magnetic Resonance Cholangio-Pancreatography
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 May 2016
Price :
$35
*
At a glance
- Drugs Ferric ammonium citrate (Primary)
- Indications Gastrointestinal disorders
- Focus Adverse reactions; Therapeutic Use
- Sponsors Otsuka Pharmaceutical
- 20 May 2016 New trial record